Much like in IBD, the pathogenic contributions of VCAM-1 in CRC are not limited purely to its ability to bind integrin for cell-to-cell adhesion, but also in downstream signalling pathways involved in endothelial dysfunction and tumour cell survival. Here, VCAM1 is linked to inflammatory bowel disease.